Valuation: NIOX Group Plc

Market Cap 290M 388M 346M 320M 546M 36.8B 555M 3.85B 1.51B 19.26B 1.46B 1.43B 61.44B P/E 2026 *
37.1x
P/E 2027 * 26.1x
Enterprise Value 263M 352M 313M 290M 494M 33.32B 502M 3.48B 1.37B 17.44B 1.32B 1.29B 55.63B EV / Sales 2026 *
5.22x
EV / Sales 2027 * 4.72x
Free-Float
79.07%
Yield 2026 *
2.68%
Yield 2027 * 3.02%
1 day-1.45%
1 week+1.77%
1 month+2.99%
3 months+16.55%
6 months+18.97%
Current year+3.92%
1 week 66
Extreme 66
70
1 month 65
Extreme 65
70
Current year 53.84
Extreme 53.84
72
1 year 53.84
Extreme 53.84
74.43
3 years 53.4
Extreme 53.4
80
5 years 29
Extreme 29
80
10 years 12.5
Extreme 12.5
115.61
Manager TitleAgeSince
Chief Executive Officer - 15/01/2025
Director of Finance/CFO - 13/05/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 58 07/02/2018
Director/Board Member - 01/09/2019
Chairman 73 04/12/2019
Date Insider Type Main position Quantity % Market Cap. Importance
29/05/26 Buy

Chief Financial Officer

34,127 0.0081%
29/05/26 Sell

Chief Financial Officer

-33,916 0.0081%
28/05/26 Sell

Chief Financial Officer

-34,219 0.0081%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+1.77%-4.17%+3.45% 387M
+3.52%+9.88%+58.45%+119.24% 1,106B
+1.97%+4.01%+33.48%+69.01% 612B
+2.21%+5.16%+24.33%+97.31% 500B
+2.58%+8.37%+38.71%+63.14% 367B
+3.27%+4.35%+71.64%+44.31% 354B
+1.85%+6.04%+21.47%+49.17% 286B
+1.76%+6.07%+0.43%+20.98% 256B
+2.56%+5.29%+43.31%+55.91% 230B
+1.89%+5.45%+26.70%+100.49% 190B
Average +1.94%+1.91%+31.44%+62.30% 390.05B
Weighted average by Cap. +2.57%+2.30%+40.54%+80.22%

Financials

2026 *2027 *
Net sales 50.36M 67.37M 59.97M 55.58M 94.65M 6.38B 96.23M 667M 262M 3.34B 253M 247M 10.66B 54.23M 72.54M 64.57M 59.84M 102M 6.87B 104M 718M 282M 3.6B 272M 266M 11.47B
Net income 8.5M 11.37M 10.12M 9.38M 15.97M 1.08B 16.24M 113M 44.22M 564M 42.65M 41.77M 1.8B 11.23M 15.03M 13.38M 12.4M 21.11M 1.42B 21.47M 149M 58.44M 745M 56.37M 55.2M 2.38B
Net Debt -27.45M -36.73M -32.69M -30.3M -51.6M -3.48B -52.46M -364M -143M -1.82B -138M -135M -5.81B -34.23M -45.79M -40.76M -37.77M -64.33M -4.34B -65.4M -453M -178M -2.27B -172M -168M -7.24B
Projected Income Statement - Annual - NIOX Group Plc
Logo NIOX Group Plc
NIOX Group plc is a United Kingdom-based diagnostics and management company. The Company is engaged in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNO), a precise biomarker for asthma. The Company's NIOX VERO is also the device of choice by clinical research organizations for respiratory studies. The device is used by healthcare professionals to improve asthma care, which assists diagnosis, determining responsiveness to inhaled corticosteroids, tailoring inhaled steroid use, monitoring treatment compliance, and reducing the likelihood of exacerbations in at-risk patients compared to traditional monitoring. The Company provides products and services via its direct sales organization and extensive distributor network in over 50 countries.
Employees
97
Date Price Change Volume
20/10/26 GBX 69.00 0.00% 338,921
19/10/26 GBX 69.00 +1.47% 399,721
16/10/26 GBX 68.00 +0.29% 190,825
15/10/26 GBX 67.80 -0.59% 467,862
14/10/26 GBX 68.20 +0.59% 938,856
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - NIOX Group Plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
0.6900GBP
Average target price
0.8240GBP
Spread / Average Target
+19.42%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - NIOX Group Plc